Medical Inhaler Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Medical Inhaler Market covers analysis By Product (Dry Powder Inhaler, Metered Dose Inhaler, Others); Application (Asthma, Chronic Obstructive Pulmonary Disorder, Others); End User (Hospitals, Clinics, Respiratory Care Center, Others) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00018804
  • Category : Medical Device
  • No. of Pages : 150
Buy Now


Medical inhalers are medical devices that are used for delivering various medication via inhalation. The medications used in the inhalers include anti-cholinergic, glucocorticoids, insulin, and beta-agonists for the treatment and prevention of respiratory diseases such as asthma and chronic obstructive pulmonary diseases. Smart inhalers are a type of medical inhalers having sensors attached as a clip on to the inhalers monitoring the right dose per intake and the technique used for inhaling the medication. The data obtained by the sensor is shared with the patient and healthcare professionals to track their inhaler usage. Other different types of inhalers include dry powder inhaler, metered-dose inhaler, and others.


The medical inhalers market has shown a significant evolution over the forecast period. The rise of the medical inhalers market is driven by the increased prevalence of people suffering from asthma and chronic obstructive pulmonary diseases and technological advancements in developing better smart inhaler devices and systems. Moreover, government initiatives toward improvising standard healthcare infrastructure and increased focus on healthcare expenditure are helping these countries to focus on offering high-quality healthcare. Elaborate efforts have been made to control the disorders such as Asthma and Chronic obstructive pulmonary disorder (COPD), which affects the majority of the people. According to WHO, more than 300 million people in the world are affected by asthma, and more than 200 million people are affected by COPD by 2016. However, the higher cost associated with medical inhalers' development for asthma and COPD is expected to restrain the medical inhalers market growth.


The "Medical Inhalers Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry's medical device, focusing on the global market trend analysis. This report outlines the medical inhalers market with detailed market segmentation by product, application, and end-user. The medical inhalers market is estimated to witness a high rise during the forecast period. It focuses on the vital statistics on the leading players' market status in the medical inhalers market and provides key opportunities and trends in the market.


The market is categorized based on the product, application, and end user. Based on the product, the market is segmented as dry powder inhaler, metered dose inhaler, and others. Based on the application, the segmentation of the market is into asthma, chronic obstructive pulmonary disorder, others. Based on end user, the segmentation of the market is into hospitals, clinics, respiratory care center, and others.


The report states a detailed outline of the industry, consisting of both quantitative and qualitative information. It offers a sketch and forecast of the medical inhalers market based on various segments. The report also consists of market size and forecast estimates from the year 2020 to2028with respect to five main regions, namely; North America, Asia-Pacific (APAC), Europe, Middle East, and Africa (MEA), and South & Central America (SCAM). The medical inhalers market by each region is then sub-segmented into respective countries and segments. It comprises the analysis and forecast of 18 countries globally and the recent trend and opportunities prevailing in the region.

The report analyzes factors affecting the medical inhalers market from both the demand and supply sides. Furthermore, it evaluates market dynamics regarding the market during the forecast period, i.e., drivers, restraints, opportunities, and future trends. It also consists of precise PEST analysis for all five regions, namely, North America, Asia Pacific, Europe, Middle East, and Africa, and South & Central America, after assessing political, social, economic, and technological factors affecting the Medical inhalers market in these regions.

Medical Inhaler Market Report Analysis

Medical Inhaler Market

  • CAGR (2023 - 2031)
  • Market Size 2023
    US$ XX Million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • GlaxoSmithKline plc.
  • Koninklijke Philips N.V.
  • AstraZeneca
  • Cipla Inc.
  • Boehringer Ingelheim International GmbH
  • Beximco Pharmaceuticals Ltd
  • Merck & Co., Inc.
  • Teva Pharmaceutical Industries Ltd
  • Chiesi Farmaceutici SpA

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

By Product
  • Dry Powder Inhaler
  • Metered Dose Inhaler
  • Others
By Application
  • Asthma
  • Chronic Obstructive Pulmonary Disorder
  • Others
By End User
  • Hospitals
  • Clinics
  • Respiratory Care Center
  • Others
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

The report contains critical developments in the medical inhalers market as inorganic and organic growth strategies. Several companies are pivoting on organic growth strategies like product launches, product approvals, and others, such as patents and events. Inorganic growth strategies observed were collaborations and acquisitions &partnerships. Various such activities have paved the path for elaborating the business and customer base of market players. The market players from the medical inhalers market are estimated to have profitable growth opportunities in the coming years with the higher demand for medical inhalers in the global market. Given below is the list of a few companies engaged in the medical inhalers market.
The report also offers key players' profiles in the medical inhalers market, along with their SWOT analysis and market strategies. Also, the report focuses on the key market players with information on company profiles, financial information of the last three years, components, and services provided, critical development in the past five years.
- GlaxoSmithKline plc.
- Koninklijke Philips N.V.
- AstraZeneca
- Cipla Inc.
- Boehringer Ingelheim International GmbH
- Beximco Pharmaceuticals Ltd
- Merck & Co., Inc.
- Teva Pharmaceutical Industries Ltd
- Chiesi Farmaceutici SpA
- Medisol Lifescience Pvt. Ltd
The Insight Partner's dedicated research and the analytical team comprises of experienced professionals with advanced statistical expertise and offers several customization options in the current report.

Medical Inhaler Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product
  • Dry Powder Inhaler
  • Metered Dose Inhaler
  • Others
By Application
  • Asthma
  • Chronic Obstructive Pulmonary Disorder
  • Others
By End User
  • Hospitals
  • Clinics
  • Respiratory Care Center
  • Others
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • GlaxoSmithKline plc.
  • Koninklijke Philips N.V.
  • AstraZeneca
  • Cipla Inc.
  • Boehringer Ingelheim International GmbH
  • Beximco Pharmaceuticals Ltd
  • Merck & Co., Inc.
  • Teva Pharmaceutical Industries Ltd
  • Chiesi Farmaceutici SpA
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    The List of Companies

    1. GlaxoSmithKline plc.
    2. Koninklijke Philips N.V.
    3. AstraZeneca
    4. Cipla Inc.
    5. Boehringer Ingelheim International GmbH
    6. Beximco Pharmaceuticals Ltd
    7. Merck & Co., Inc.
    8. Teva Pharmaceutical Industries Ltd
    9. Chiesi Farmaceutici SpA
    10. Medisol Lifescience Pvt. Ltd

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • 3.1 Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • 3.2 Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • 3.3 Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • 3.4 Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Trends and growth analysis reports related to Medical Inhaler Market